Floating Button
Home Capital Broker's Calls

Maybank ups target price on Raffles Medical Group amid better re-rating catalysts

Samantha Chiew
Samantha Chiew • 3 min read
Maybank ups target price on Raffles Medical Group amid better re-rating catalysts
RMG's CEO Dr Loo Choon Yong is optimistic about the China market as the group gains traction there. Photo: Albert Chua/ The Edge Singapore
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Maybank Securities is reiterating its "buy" recommendation on Raffles Medical Group (SGX:BSL) (RMG) but with a higher target price of $1.13 from $1.03 previously, given the group's more optimal capital structure. RMG is also the research house's top pick in the Singapore healthcare sector.

Analyst Eric Ong notes that the group has recently signed an agreement with an affiliate of Shanghai Jiao Tong University School of Medicine to work on a new model of collaboration between public hospitals and international medical groups.

The affiliate, Renji Hospital, and RFMD will establish a "dual circulation" medical resource service system, to advance a new model of collaborative development and promote Shanghai as an international medical tourism hub.

×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2026 The Edge Publishing Pte Ltd. All rights reserved.